论文部分内容阅读
常州东风医院气管炎研究室和常州生化药厂研制的P-胎盘脂多糖注射液于8月18日通过了技术鉴定。本品是一种免疫增强剂,系用猪胎盘粉经酶解、除蛋白、醇析、透析后制得的脂多糖灭菌水溶液,每支2ml,含0.5mg。经分析,本品是一种酸性粘多糖,分子中含氨基己糖、己糖醛酸、半乳糖、岩藻糖、阿拉伯糖、木糖、甘露糖、葡萄糖等、据红外光谱、氧肟酸盐和酯化法分析,本品含结合状态脂质。
Changzhou Dongfeng Hospital Tracheitis Research Laboratory and Changzhou Shenghua Pharmaceutical Co., Ltd. developed P-placental lipopolysaccharide injection on August 18 passed the technical appraisal. This product is an immune enhancer. It is a sterile solution of lipopolysaccharide prepared by enzymatic hydrolysis, protein removal, alcohol precipitation, and dialysis in pig placental powder, each containing 2 ml, containing 0.5 mg. After analysis, this product is an acid mucopolysaccharide containing hexosamine, hexuronic acid, galactose, fucose, arabinose, xylose, mannose, glucose, etc. in the molecule, according to infrared spectrum, oxalic acid Salt and esterification analysis, the product contains bound lipids.